As of 2026-04-03, the Fair Value of Polydex Pharmaceuticals Ltd (POLXF) is -0.21 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 1.99 USD, the upside of Polydex Pharmaceuticals Ltd is -110.39%.
With the market price of 1.99 USD and our fair value calculation, Polydex Pharmaceuticals Ltd (POLXF) is not a good investment. Investing in POLXF stocks now will result in a potential loss of 110.39%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2017-01-31 | 2018-01-31 | 2019-01-31 | 2020-01-31 | 2021-01-31 | 5Y Avg | |
| Net income | 0.67 | 0.45 | 0.23 | 0.25 | 0.21 | 0.36 |
| YoY growth | -47.61% | -33.06% | -48.45% | 8.63% | -15.62% | -27.22% |
| Market Cap (mil) | 6.71 |
| P/E | |
| Forward P/E | 34.72x |
| EPS | -0.04 |
| Avg earnings growth rate | -27.22% |
| TTM earnings | -0.14 |